These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2. Levine-Tiefenbrun M; Yelin I; Alapi H; Katz R; Herzel E; Kuint J; Chodick G; Gazit S; Patalon T; Kishony R Nat Med; 2021 Dec; 27(12):2108-2110. PubMed ID: 34728830 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study. Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P; BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968 [TBL] [Abstract][Full Text] [Related]
8. Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load. Migueres M; Dimeglio C; Trémeaux P; Raymond S; Lhomme S; Da Silva I; Oliveira Mendes K; Abravanel F; Félicé MP; Mansuy JM; Izopet J Viruses; 2022 Feb; 14(2):. PubMed ID: 35215916 [TBL] [Abstract][Full Text] [Related]
9. NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals. Cuapio A; Boulouis C; Filipovic I; Wullimann D; Kammann T; Parrot T; Chen P; Akber M; Gao Y; Hammer Q; Strunz B; Pérez Potti A; Rivera Ballesteros O; Lange J; Muvva JR; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Söderdahl G; Österborg A; Smith CIE; Bogdanovic G; Muschiol S; Hellgren F; Loré K; Sobkowiak MJ; Gabarrini G; Healy K; Sällberg Chen M; Alici E; Björkström NK; Buggert M; Ljungman P; Sandberg JK; Aleman S; Ljunggren HG Mol Med; 2022 Feb; 28(1):20. PubMed ID: 35135470 [TBL] [Abstract][Full Text] [Related]
10. Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection. Nemet I; Kliker L; Lustig Y; Zuckerman N; Erster O; Cohen C; Kreiss Y; Alroy-Preis S; Regev-Yochay G; Mendelson E; Mandelboim M N Engl J Med; 2022 Feb; 386(5):492-494. PubMed ID: 34965337 [No Abstract] [Full Text] [Related]
11. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California. Servellita V; Morris MK; Sotomayor-Gonzalez A; Gliwa AS; Torres E; Brazer N; Zhou A; Hernandez KT; Sankaran M; Wang B; Wong D; Wang C; Zhang Y; Reyes KR; Glasner D; Deng X; Streithorst J; Miller S; Frias E; Rodgers M; Cloherty G; Hackett J; Hanson C; Wadford D; Philip S; Topper S; Sachdev D; Chiu CY Nat Microbiol; 2022 Feb; 7(2):277-288. PubMed ID: 35013591 [TBL] [Abstract][Full Text] [Related]
12. Waning Immunity after the BNT162b2 Vaccine in Israel. Goldberg Y; Mandel M; Bar-On YM; Bodenheimer O; Freedman L; Haas EJ; Milo R; Alroy-Preis S; Ash N; Huppert A N Engl J Med; 2021 Dec; 385(24):e85. PubMed ID: 34706170 [TBL] [Abstract][Full Text] [Related]
13. Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults. Romero-Olmedo AJ; Schulz AR; Hochstätter S; Das Gupta D; Virta I; Hirseland H; Staudenraus D; Camara B; Münch C; Hefter V; Sapre S; Krähling V; Müller-Kräuter H; Widera M; Mei HE; Keller C; Lohoff M Nat Microbiol; 2022 Feb; 7(2):195-199. PubMed ID: 35013593 [TBL] [Abstract][Full Text] [Related]
14. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History. Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S Front Immunol; 2021; 12():793191. PubMed ID: 34975897 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of BNT162b2 vaccine after two and three doses: Correspondence. Daungsupawong H; Wiwanitkit V Semergen; 2024; 50(4):102132. PubMed ID: 38295632 [No Abstract] [Full Text] [Related]
16. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675 [TBL] [Abstract][Full Text] [Related]
17. Do health-care workers need a COVID-19 vaccine booster? Cirillo N Lancet Infect Dis; 2022 Jan; 22(1):20. PubMed ID: 34953546 [No Abstract] [Full Text] [Related]
19. Three, four or more: what's the magic number for booster shots? Watson C Nature; 2022 Feb; 602(7895):17-18. PubMed ID: 35091715 [No Abstract] [Full Text] [Related]
20. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Levine-Tiefenbrun M; Yelin I; Katz R; Herzel E; Golan Z; Schreiber L; Wolf T; Nadler V; Ben-Tov A; Kuint J; Gazit S; Patalon T; Chodick G; Kishony R Nat Med; 2021 May; 27(5):790-792. PubMed ID: 33782619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]